Federal grants to Intervexion Therapeutics LLC
Intervexion Therapeutics LLC in Little Rock, Arkansas received $33.9 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Drug Use and Addiction Research Programs, with $33.9 million. In fiscal 2025 more was taken back from its awards than added, a net -$192,145.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$33.9 million
- Awards4
- Awarded in FY 2025-$192,145
- Largest award$13.8 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $11.5 million |
| FY 2022 | 4 | $9.8 million |
| FY 2023 | 2 | $8.8 million |
| FY 2024 | 1 | $4.0 million |
| FY 2025 | 0 | -$192,145 |
Programs that fund Intervexion Therapeutics LLC
| Program | Awards | Amount |
|---|---|---|
| Drug Use and Addiction Research Programs | 4 | $33.9 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $33.9 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Outlast - a first multiple-dose efficacy study of IXT-M200, an anti-meth monoclonal antibody, in patients with meth use disorder - project abstract methamphetamine use disorder (MUD) is a significant health concern in the us with no approved medications for treatment. This application aims to test i | Drug Use and Addiction Research Programs | September 22, 2021 | $13.8 million |
| Ind-enabling program for a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder - project abstract nearly 1 million people in the us were diagnosed with a methamphetamine (METH) use disorder (MUD) in 2017. Once established, mud can last a long time and is ve | Drug Use and Addiction Research Programs | September 19, 2022 | $9.9 million |
| Meth-od: a phase 2A study of IXT-M200 in methamphetamine overdose patients | Drug Use and Addiction Research Programs | November 13, 2020 | $5.4 million |
| Optimization and testing of anti-methamphetamine antibody therapy to support pivotal clinical trials and commercialization | Drug Use and Addiction Research Programs | March 1, 2021 | $4.9 million |
Questions people ask
How much federal grant money does Intervexion Therapeutics LLC get?
$33.9 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Intervexion Therapeutics LLC the most?
The Department of Health and Human Services, with $33.9 million in 4 awards.
What is Intervexion Therapeutics LLC's largest federal grant?
$13.8 million under Drug Use and Addiction Research Programs, with its first action in the period on September 22, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in Little Rock
- Arkansas Department of Human Services
- Department of Education Arkansas
- Arkansas Department of Transportation
- Arkansas Department of Human Services
- Arkansas Economic Development Commission
- Arkansas Department of Health
- University of Arkansas for Medical Sciences
- Arkansas Division of Workforce Services
Largest federal grant recipients in Arkansas · Federal grants in Arkansas